20103 ⎘
Medicinal preparations characterised by special physical form; Pills, tablets, discs, rods; Excipients; Inactive ingredients; Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
ORAL DOSAGE FORM
#1502Sustained release oral dosage form containing dalfampridine
#1503Surfactant-free HIV protease inhibitor composition and method of manufacturing thereof
#1504GABA analog prodrug sustained release oral dosage forms
#1505ORAL FORMULATIONS OF PYRROLIDINE DERIVATIVES
#1506Pharmaceutical formulation containing gelling agent
#1507Pharmaceutical Formulation Containing Gelling Agent
#1508Modified release preparations containing oxcarbazepine and derivatives thereof
#1509DAPAGLIFLOZIN COMPOSITIONS
#1510Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
#1511SUSTAINED RELEASE ORAL PHARMACEUTICAL COMPOSITIONS OF TOFACITINIB
#1512Abuse Deterrent Compositions and Methods of Making Same
#1513Methods of treating posttraumatic stress disorder with acamprosate salts
#1514Pharmaceutical compositions comprising hemp and turmeric to treat pain and inflammation
#1515Composition for treatment of essential thrombocythemia
#1516PHARMACEUTICAL COMPOSITION COMPRISING LACOSAMIDE AND LEVETIRACETAM
#1517SIP MODULATOR IMMEDIATE RELEASE DOSAGE REGIMEN
#1518High-loading, controlled-release magnesium oral dosage forms and methods for making and using same
#1519Pharmaceutical formulation containing gelling agent
#1520Pharmaceutical formulation containing gelling agent
#1521Formulation of syk inhibitors
#1522PHARMACEUTICAL FORM FOR COMBATING CHEMICAL SUBMISSION OF A MEDICAMENT
#1523PHARMACEUTICAL COMPOSITION
#1524ABUSE-RESISTANT CONTROLLED-RELEASE OPIOID DOSAGE FORM
#1525Vildagliptin Formulation Process Under Inert Gas Atmosphere
#1526Pharmaceutical formulations of vildagliptin
#1527Orally Disintegrating Tablet of Nabilone Comprising Mannitol-Based Granules
#1528Crystalline form of oxazolidinone antibiotics and preparation method, composition and use thereof
#1529Extruded extended release abuse deterrent pill
#1530Pharmaceutical composition with improved bioavailability
#1531Abuse-proofed dosage form
#1532Solid Pharmaceutical Compositions for Treating HCV
#1533Solid Pharmaceutical Compositions for Treating HCV
#1534Pharmaceutical compositions
#1535ORODISPERSIBLE DOSAGE UNIT CONTAINING AN ESTETROL COMPONENT
#1536Use of a receptor-type kinase modulator for treating polycystic kidney disease
#1537Pharmaceutical compositions of sitagliptin
#1538Naloxone single agent and multilayer tablets
#1539Process for the production of an abuse-proofed dosage form
#1540Rapidly dispersible dosage form of topiramate
#1541Treatment of metabolic disorders in canine animals
#1542COMBINATION FORMULATION CONTAINING SUSTAINED RELEASE METFORMIN AND IMMEDIATE RELEASE HMG-COA REDUCTASE INHIBITOR
#1543Pressurised metered dose inhalers and method of manufacture
#1544Process of preparing pharmaceutical compositions for the treatment of CFTR mediated diseases
#1545Compartmented pharmaceutical dosage forms
#1546Fixed-Dose Combinations of Antiviral Compounds
#1547Procaspase 3 activation by combination therapy
#1548Pharmaceutical Composition Comprising Apixaban
#1549Solid dispersions of insoluble drug and preparation method thereof
#1550COMPOSITION AND METHOD FOR AIDING SLEEP
#1551Tablet formulation for CGRP active compounds
#1552Composite formulation for oral administration comprising ezetimibe and rosuvastatin
#1553Pharmaceutical formulations
#1554NOVEL DISINTEGRATION SYSTEMS FOR PHARMACEUTICAL DOSAGE FORMS
#1555Peptide Pharmaceutical for Oral Delivery
#1556STABILIZED GASTRORETENTIVE TABLETS OF PREGABALIN
#1557SUSTAINED RELEASE FORMULATION
#1558Parenteral formulations of dopamine agonists
#1559Pharmaceutical Compositions for the Treatment of CFTR Mediated Diseases
#1560Pharmaceutical Composition Comprising Deferasirox
#1561Pharmaceutical composition containing clomipramine and preparation method therefor
#1562Method for the production of a molding
#1563Ingestible formulations for transient, noninvasive reduction of gastric volume
#1564COMPOSITIONS OF GRAPIPRANT AND METHODS FOR USING THE SAME
#1565Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors
#1566Immediate release abuse-deterrent granulated dosage forms
#1567Extruded extended release abuse deterrent pill
#1568Delayed Release Compositions of Linaclotide
#1569Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
#1570Methylphenidate extended release chewable tablet
#1571ORODISPERSIBLE TABLETS
#1572Modified release formulations containing drug-ion exchange resin complexes
#1573Modified release formulations containing drug - ion exchange resin complexes
#1574Controlled release and taste masking oral pharmaceutical composition
#1575DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION
#1576Acrylic Polymer Formulations
#1577MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION
#1578Controlled release dosage form for once daily administration of dimethyl fumarate
#1579Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof
#1580Dihydroorotic and acid dehydrogenase inhibitor
#1581Multicomponent gummy compositions with hard core
#1582Multicomponent gummy compositions with soft core
#1583RAPIDLY DISINTEGRATING FORMULATIONS AND METHODS THEREOF
#1584Magnesium-containing products and uses thereof
#1585ORAL DISPERSIBLE COMPOSITION OF A DPP-IV INHIBITOR
#1586METHODS FOR THE TREATMENT OF ABNORMAL INVOLUNTARY MOVEMENT DISORDERS
#1587Modified Release Tranexamic Acid Formulation
#1588CETP MODULATOR FOR USE IN THE TREATEMENT OF EYE DISEASE
#1589Multilayer solid pharmaceutical dosage forms
#1590Method of treating melanoma by administration of pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate
#1591PHARMACEUTICAL COMPOSITION
#1592Formulations containing nalbuphine and uses thereof
#1593Alternating sympathomimetic therapy for the treatment of respiratory ailments
#1594Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
#1595Substituted pyrimidines for treatment of a cough selected from chronic pathological cough, sub-acute pathological cough, acute pathological cough, neuronal hypersensitivity underlying chronic cough, neuronal hypersensitivity underlying sub-acute cough and neuronal hypersensitivity underlying acute cough
#1596Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent
#1597TABLET
#1598Abuse-proofed dosage form
#1599Highly compactable and durable direct compression excipients and excipient systems
#1600Formulations Containing Amorphous Dapagliflozin
#1601Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor
#1602Delayed release tablet with defined core geometry
#1603ABUSE-DETERRENT DOSAGE FORMS
#1604Fast disintegrating compositions and tablets thereof
#1605TRIPULSE RELEASE STIMULANT FORMULATIONS
#1606Solid Pharmaceutical Compositions Containing Pregabalin
#1607Rapidly dispersible dosage form of oxcarbazepine
#1608Tacrolimus for improved treatment of transplant patients
#1609Modified release compositions comprising tacrolimus
#1610Formulations of 5-fluorocytosine and uses thereof
#1611Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#1612Controlled release hydrocodone formulations
#1613Pharmaceutical Formulation
#1614PURIFIED CBD AND CBDA, AND METHODS, COMPOSITIONS AND PRODUCTS EMPLOYING CBD OR CBDA
#1615MONOMETHYLFUMARATE PRODRUG COMPOSITIONS
#1616PHARMACEUTICAL COMPOSITION OF BUPROPION AND NALTREXONE
#1617ORAL FORMULATIONS OF DEFERASIROX
#1618SOLID DISPERSION OF A SELECTIVE MODULATOR OF THE PROGESTERONE RECEPTOR
#1619COMPOSITIONS AND METHODS USING FLUMAZENIL WITH OPIOID ANALGESICS FOR TREATING PAIN AND/OR ADDICTION, AND WITH DIVERSION AND/OR OVERDOSE MITIGATION
#1620INTRAORALLY DISINTEGRABLE TABLET COMPRISING DISINTEGRABLE GRANULAR COMPOSITION
#1621LACTOFERRIN FOR THE TREATMENT OF IBD ASSOCIATED WITH BACTERIAL INVASION
#1622Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
#1623Methods and compositions for self-regulated release of active pharmaceutical ingredient
#1624METHOD FOR THE TREATMENT, ALLEVIATION OF SYMPTOMS OF, RELIEVING, IMPROVING AND PREVENTING A COGNITIVE DISEASE, DISORDER OR CONDITION
#1625Single-layer oral dose of neuro-attenuating ketamine
#1626Methods for intravesical drug delivery and methods and systems for loading devices with drug tablets
#1627TRANSMUCOSAL DELIVERY OF GLATIRAMER ACETATE
#1628STABLE CRYSTAL I-FORM AGOMELATINE TABLET AND PREPARATION METHOD THEREOF
#1629Tablet comprising crospovidone
#1630Solid oral dosage formulation of HCV inhibitor in the amorphous state
#1631Polymer, and pharmaceutical composition employing the same
#1632Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract
#1633DEFERACIROX DISPERSIBLE TABLETS
#1634Formulation of Syk inhibitors
#1635Solid dispersions comprising tacrolimus
#1636Modified release formulations containing drug-ion exchange resin complexes
#1637Antitubercular composition comprising rifampicin, isoniazid, ethambutol and pyrazinamide and its process of preparation
#1638Controlled release hydrocodone formulations
#1639Controlled release hydrocodone formulations
#1640Pharmaceutical formulation containing gelling agent
#1641Doxycycline composition
#1642Pharmaceutical composition of doxycycline with reduced food effect
#1643Controlled release hydrocodone formulations
#1644Pharmaceutical formulation containing gelling agent
#1645Pharmaceutical formulation containing gelling agent
#1646Pharmaceutical formulation containing gelling agent
#1647Pharmaceutical formulation containing gelling agent
#1648Pharmaceutical formulation containing gelling agent
#1649FORMULATION OF A MICRO DROP PILL AND THE PREPARATION METHOD THEREOF
#1650Controlled release hydrocodone formulations
#1651Pharmaceutical formulation containing gelling agent
#1652Controlled release hydrocodone formulations
#1653Pharmaceutical formulation containing gelling agent
#1654Oral Pharmaceutical Compositions Comprising Imatinib Mesylate
#1655Methylphenidate extended release chewable tablet
#1656ORALLY DISINTEGRATING EXCIPIENT
#1657Controlled release oral dosage forms of poorly soluble drugs and uses thereof
#1658CONTROLLED RELEASE CAFFEINE DOSAGE FORMS
#1659Coprocessed silica coated polymer composition
#1660STABLE CRYSTAL X-FORM AGOMELATINE TABLET AND PREPARATION METHOD THEREOF
#1661Orally disintegrating tablet formulation for enhanced bioavailability
#1662METHODS OF PREPARING EXTRUDATES
#1663Swallowable N-acetylcysteine tablets
#1664Pharmaceutical compositions
#1665HIGH DRUG LOAD TABLET
#1666Acamprosate formulations, methods of using the same, and combinations comprising the same
#1667Beta-lactamase formulations and uses thereof
#1668STABILITY OF PROGESTOGEN FORMULATIONS
#1669Orally disintegrable tablet
#1670ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME
#1671Immunomodulators and immunomodulator conjugates
#1672Composition of a 5-HTserotonin receptor modulator useful for the treatment of disorders related thereto
#1673Methods of treating infections in overweight and obese patients using antibiotics
#1674Plurimodal release formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
#1675Pharmaceutical compositions
#1676Guidewire/ partial occluder for intraluminal travel
#1677Tamper resistant pharmaceutical formulations
#1678Pramipexole sustained release tablet formulation and manufacturing method thereof and use thereof
#1679Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof
#1680Oxycodone formulations
#1681Compositions and methods of using (R)-pramipexole
#1682Dual drug dosage forms with improved separation of drugs
#1683Oral disintegrating tablet
#1684DPP IV INHIBITOR FORMULATIONS
#1685Pharmaceutical combination drug
#1686Dosage Form Comprising Crizotinib
#1687Compositions and methods for reducing overdose
#1688Formulation containing carbidopa, levodopa, and entacapone
#1689Methylphenidate extended release chewable tablet
#1690Oral delivery system for sorafenib tosylate
#1691Formulations of organic compounds
#1692Pharmaceutical composition of doxycycline with reduced food effect
#1693PHARMACEUTICAL FORMULATIONS COMPRISING QUETIAPINE AND ESCITALOPRAM
#1694Controlled release compositions
#1695FORMULATIONS OF MAZINDOL
#1696Drug delivery system to increase bioavailability
#1697Pharmaceutical compositions comprising Tadalafil
#1698Methods and compositions for self-regulated release of active pharmaceutical ingredient
#1699Pharmaceutical formulation containing gelling agent
#1700Pharmaceutical formulation containing irritant
#1701DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
#1702Sustained-release solid preparation for oral use
#1703Rapidly dispersible dosage form of oxcarbazepine
#1704Rapidly dispersible dosage form of topiramate
#1705Coprocessed silica coated polymer composition
#1706Modified release preparations containing oxcarbazepine and derivatives thereof
#1707Modified release preparations containing oxcarbazepine and derivatives thereof
#1708Spray dried compositions having different dissolution profiles and processes for their preparation
#1709Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse
#1710Prolonged-release diphenidol composition
#1711VALSARTAN-AMLODIPINE COMPOUND SOLID PREPARATION AND PREPARATION METHOD THEREFOR
#1712Pharmaceutical compositions for gastrointestinal drug delivery
#1713Pharmaceutical composition
#1714FORMULATION FOR CO-THERAPY TREATMENT OF DIABETES
#1715High-loading, controlled-release magnesium oral dosage forms and methods for making and using same
#1716Orodispersible tablets obtained by compression molding
#1717Pharmaceutical compositions and methods for fabrication of solid masses comprising anti-interleukin antibodies
#1718Pharmaceutical compositions and methods for fabrication of solid masses comprising TNF-inhibiting antibodies
#1719Pharmaceutical compositions and methods for fabrication of solid masses comprising immunoglobulins
#1720Pharmaceutical compositions and methods for fabrication of solid masses comprising glucose regulating proteins
#1721Tablet composition comprising cinacalcet hydrochloride
#1722Dosage form for insertion into the mouth
#1723Abuse deterrent immediate release coated reservoir solid dosage form
#1724TABLET QUICKLY DISINTEGRATING IN THE ORAL CAVITY AND METHOD FOR PRODUCING THE SAME
#1725PHARMACEUTICAL COMPOSITIONS CONTAINING A DGAT1 INHIBITOR
#1726Pharmaceutical compositions
#1727Combination uses of dichloroacetate and oxamate, and their prodrugs, for cancer treatment
#1728Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same
#1729PROLONGED-RELEASE MULTIMICROPARTICULATE ORAL PHARMACEUTICAL FORM
#1730Pharmaceutical compositions
#1731HIGH DRUG LOAD TABLET FORMULATION OF [(1R), 2S]-2-AMINOPROPIONIC ACID 2-[4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-5-METHYLPYRROLO[2,1-f][1,2,4]TRIAZIN-6-YLOXY]-1-METHYLETHYL ESTER
#1732Pharmaceutical composition for treatment of HIV infection
#1733Pharmaceutical compositions
#1734Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as Excipient
#1735Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as Excipient
#1736Method for improving the bioavailability of low aqueous solubility drugs
#1737TRANEXAMIC ACID FORMULATIONS
#1738Pharmaceutical formulation containing gelling agent
#1739Solid dispersions of insoluble drug and preparation method thereof
#1740TABLET FORMULATIONS CONTAINING 8-[-METHYL]-8-PHENYL-1,7-DIAZA-SPIRO[4.5]DECAN-2-ONE SALTS AND TABLETS MADE THEREFROM
#1741Orally disintegrating tablets and methods of manufacture
#1742Disintegrating monolithic modified release tablets containing quadri-layer extended release granules
#1743VAGINAL DANAZOL COMBINED WITH NON STEROIDAL ANTI INFLAMMATORY DRUGS (NSAIDS) COMPOSITIONS
#1744Rapidly dissolving pharmaceutical composition
#1745Abuse deterrent immediate release biphasic matrix solid dosage form
#1746Modified release formulations containing drug-ion exchange resin complexes
#1747DOSAGE FORMS COMPRISING APIXABAN AND MATRIX FORMER
#1748MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION
#1749MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION
#1750Pharmaceutical composition
#1751Pharmaceutical formulation containing gelling agent
#1752USE OF MOISTURE-CONDITIONED DISINTEGRANTS OR EXPANDING AGENTS IN TABLET MANUFACTURE FOR THE SELECTIVE ADJUSTMENT OF THE MECHANICAL PROPERTIES, THE DISSOLVING KINETICS AND/OR THE WATER LOADING OF THE TABLETS
#1753Controlled release hydrocodone formulations
#1754Controlled release hydrocodone formulations
#1755Controlled release hydrocodone formulations
#1756CHEWABLE TABLETS COMPRISING LEVONORGESTREL
#1757Treatment of diarrhea and post-weaning diarrhea with resistant potato starch
#1758Compositions of grapiprant and methods for using the same
#1759Abuse resistant oral dosage forms
#1760Pharmaceutical composition
#1761Solid oral compositions of tolvaptan
#1762CRUSH-RESISTANT TABLETS INTENDED TO PREVENT ACCIDENTAL MISUSE AND UNLAWFUL DIVERSION
#1763Triazolyl derivatives as Syk inhibitors
#1764Pharmaceutical formulation containing gelling agent
#1765Granular material for orally fast disintegrating tablets
#1766Disintegrating particle composition containing acid-type carboxymethylcellulose and crystalline cellulose, and orally disintegrating tablet containing said composition
#1767TAMPER-RESISTANT DOSAGE FORM COMPRISING PHARMACOLOGICALLY ACTIVE COMPOUND AND ANIONIC POLYMER
#1768Controlled release hydrocodone formulations
#1769Pharmaceutical composition
#1770DELAYED RELEASE POSACONAZOLE TABLETS
#1771PHARMACEUTICAL COMPOSITION COMPRISING AN ATYPICAL ANTIPSYCHOTIC AGENT AND METHOD FOR THE PREPARATION THEREOF
#1772Stable pharmaceutical composition containing 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione or a pharmaceutically acceptable salt thereof
#1773EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE
#1774Controlled release hydrocodone formulations
#1775Controlled release hydrocodone formulations
#1776Preparation containing 6,7-unsaturated-7-carbamoyl morphinan derivatives
#1777NOVEL ORALLY ADMINISTERED PHARMACEUTICAL FORMULATIONS
#1778Mucoadhesive polymers having vitamin B partial structures
#1779PHARMACEUTICAL COMPOSITION AND PROCESS
#1780HIGH DRUG LOAD TABLET
#1781Fast Dissolving Ocular Insert
#1782Tamper resistant pharmaceutical formulations
#1783Modified release formulations of a bupropion salt
#1784Tamper resistant pharmaceutical formulations
#1785Methods of preparing tamper resistant pharmaceutical formulations
#1786Tamper resistant pharmaceutical formulations
#1787Solid dosage formulations of an orexin receptor antagonist
#1788SOLID DRUG TABLETS FOR IMPLANTABLE DRUG DELIVERY DEVICES
#1789COMPOSITIONS AND METHODS FOR TREATMENT OF ABNORMAL CELL GROWTH
#1790Amide compound
#1791Pharmaceutical composition containing phosphate binding polymer
#1792Shell-and-core dosage form approaching zero-order drug release
#1793Dissolution enhanced controlled drug delivery system for poorly water soluble drugs
#1794Extruded extended release abuse deterrent pill
#1795FORMULATIONS FOR THE PREPARATION OF IMMEDIATE-RELEASE TABLETS FOR ORAL USE CONTAINING LOW-DOSE MIFEPRISTONE FOR THE TREATMENT OF ENDOMETRIOSIS, TABLETS THUS OBTAINED AND THEIR PREPARATION PROCESS
#1796Oral formulations of pyrrolidine derivatives
#1797Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract
#1798MEDICINE
#1799Pharmaceutical Formulations Comprising Vilazodone
#1800Methylphenidate extended release chewable tablet